Extracellular Zn 2ϩ modulates current passage through voltageand neurotransmitter-gated ion channels, at concentrations less than, or near, those produced by release at certain synapses. Electrophysiological effects of cytoplasmic Zn 2ϩ are less well understood, and effects have been observed at concentrations that are orders of magnitude greater than those found in resting and stimulated neurons. To examine whether and how neurons are affected by lower levels of cytoplasmic Zn 2ϩ , we tested the effect of Zn 2ϩ -selective chelators, Zn 2ϩ -preferring ionophores, and exogenous Zn 2ϩ on neuronal somata during whole-cell patch-clamp recordings. We report here that cytoplasmic zinc facilitates the downward regulation of a background Cl Ϫ conductance by an endogenous protein kinase C (PKC) in fish retinal ganglion cell somata and that this regulation is maintained if nanomolar levels of free Zn 2ϩ are available. This regulation has not been described previously in any tissue, as other Cl Ϫ currents have been described as reduced by PKC alone, reduced by Zn 2ϩ alone, or reduced by both independently. Moreover, control of cation currents by a zinc-dependent PKC has not been reported previously. The regulation we have observed thus provides the first electrophysiological measurements consistent with biochemical measurements of zinc-dependent PKC activity in other systems. These results suggest that contributions of background Cl Ϫ conductances to electrical properties of neurons are susceptible to modulation.
Extracellular Zn 2ϩ modulates current passage through voltageand neurotransmitter-gated ion channels, at concentrations less than, or near, those produced by release at certain synapses. Electrophysiological effects of cytoplasmic Zn 2ϩ are less well understood, and effects have been observed at concentrations that are orders of magnitude greater than those found in resting and stimulated neurons. To examine whether and how neurons are affected by lower levels of cytoplasmic Zn 2ϩ , we tested the effect of Zn 2ϩ -selective chelators, Zn 2ϩ -preferring ionophores, and exogenous Zn 2ϩ on neuronal somata during whole-cell patch-clamp recordings. We report here that cytoplasmic zinc facilitates the downward regulation of a background Cl Ϫ conductance by an endogenous protein kinase C (PKC) in fish retinal ganglion cell somata and that this regulation is maintained if nanomolar levels of free Zn 2ϩ are available. This regulation has not been described previously in any tissue, as other Cl Ϫ currents have been described as reduced by PKC alone, reduced by Zn 2ϩ alone, or reduced by both independently. Moreover, control of cation currents by a zinc-dependent PKC has not been reported previously. The regulation we have observed thus provides the first electrophysiological measurements consistent with biochemical measurements of zinc-dependent PKC activity in other systems. These results suggest that contributions of background Cl Ϫ conductances to electrical properties of neurons are susceptible to modulation.
Key words: background chloride conductance; resting potential; outward rectification; PKC; Zn 2ϩ ; divalent cation Calcium, magnesium, and zinc are found in both bound and ionized forms in neuronal and muscle cytoplasm. Of these, the concentration and physiological effects of unbound intracellular calcium (C a 2ϩ ) have been studied most extensively. Fluorescent indicators and patch-clamp methods have shown substantial agreement between the endogenous free C a 2ϩ levels measured during certain electrophysiological responses and buffered levels of exogenous C a 2ϩ that can elicit those events (e.g., Johnson and Byerly, 1993; Roberts, 1993; Burgoyne and Morgan, 1995; Etter et al., 1996) . Recent measurements suggest a similar correlation for Mg 2ϩ , in that free intracellular Mg 2ϩ concentrations range from 0.6 to 5 mM (Brocard et al., 1993) and thus span the range of Mg 2ϩ levels that gate or regulate ion channels (e.g., Matsuda et al., 1987; Stelzer et al., 1988; Johnson and Ascher, 1990; O'Rourke et al., 1992) . By comparison, electrophysiological effects of cytoplasmic Z n 2ϩ have been reported rarely, and these effects have been obtained with Z n 2ϩ concentrations that are several orders of magnitude greater than the picomolar-tomicromolar levels found in recent histochemical studies (Begenisich and Lynch, 1974; Woll et al., 1987; Frederickson, 1989; Kokubun et al., 1991; Groschner and Kukovetz, 1992; Staley, 1994; Lascola et al., 1998; Sensi et al., 1997) . We therefore tested whether and how neurons are affected electrophysiologically by lower concentrations of cytoplasmic Z n 2ϩ and by changes in these levels. For this purpose, we applied various combinations of Zn 2ϩ , Zn 2ϩ -selective chelators, and Zn 2ϩ -preferring ionophores to isolated neuronal somata during perforated-and ruptured-patch whole-cell patch-clamp recordings. We specifically tested for these effects in neurons that contain protein kinase C (PKC) (cf. Cuenca et al., 1990; Osborne et al., 1992) , because biochemical studies have shown that Zn 2ϩ binds PKC and facilitates its activity at submicromolar concentrations (Murakami et al., 1987; Csermely et al., 1988; Sekiguchi et al., 1988; Forbes et al., 1991; Hubbard et al., 1991) . We present evidence here that intracellular zinc facilitates the reduction of a "background" Cl Ϫ conductance (Franciolini and Petris, 1990) by an endogenous PKC in retinal ganglion cells.
The results below are presented in two parts. The first identifies an outwardly rectifying Cl Ϫ current that constitutes a background Cl Ϫ conductance in retinal ganglion cells. The second part provides evidence that regulation of this current by endogenous PKC is zinc dependent.
Portions of these data have appeared in a meeting abstract (Tabata and Ishida, 1997) .
MATERIALS AND METHODS
W hole-cell recordings. The voltage-clamp currents described here were measured in single, neurite-free retinal ganglion cell somata isolated from adult common goldfish (Carassius auratus). C ells were isolated and identified as described elsewhere (see Bindokas et al., 1994; Tabata and Ishida, 1996; Hidaka and Ishida, 1998) . Currents were measured in tight-seal whole-cell configurations, in either ruptured-or perforatedpatch mode (Hamill et al., 1981; Horn and Marty, 1988) . E xperiments were performed at ϳ23°C within 20 hr of cell isolation, using borosilicate glass pipettes with tip resistances of 2-3 M⍀ and an Axopatch-1D amplifier (Axon Instruments, Foster C ity, CA).
During recording, cells were continuously superf used with a control bath solution (see below) at a rate of 1.2 ml /min. To reduce the time required to change extracellular solution composition and to ensure that current changes were not attributable to mechanical artifacts, we applied control and test solutions sequentially to cells, either by switching be-tween fluid reservoirs fed into a microperf usion U-tube or by shifting the position of a parallel array of glass tubes that each superf used a different solution over the cells being recorded. As described elsewhere (Tabata and Ishida, 1996) , command potential generation, data storage, and off-line analysis were performed with pCL AM P software (version 6.0.3; Axon Instruments); capacitive currents were reduced as much as possible by use of the cancellation circuitry of the amplifier; current signals were analog-filtered at 1 kHz and digitally sampled at 2 kHz; and liquid junction potentials between pipette and bath solutions were measured and corrected for before data collection. Membrane potentials are reported without compensation for series resistance (mean Ϯ SEM; 18 Ϯ 1 M⍀ in ruptured-patch mode; n ϭ 65; 32 Ϯ 4 M⍀ in perforated-patch mode; n ϭ 46) because the total membrane current rarely exceeded 200 pA. Unless otherwise indicated, data are reported here as mean values Ϯ 1 SEM from the indicated number (n) of cells. The current amplitudes reported are the mean values recorded during the final 20 msec of 100 msec steps to each test potential. Changes in current amplitudes measured under various conditions were compared by Wilcoxon rank-sum tests because these values did not distribute normally. Variances of data measured with different pipette solutions (e.g., see Fig. 3C ) were compared by F tests (by comparing the ratio of the variances).
Solutions. The compositions of the routinely used pipette and bath solutions are as follows (exceptions are noted in the figure legends). In ruptured-patch mode, the 30 nM Zn 2ϩ -containing pipette solution consisted of (in mM): 150 N-methyl-D-glucamine (NMDG), 0.226 C aC l 2 , 1.7 MgC l 2 , 3.6 ZnCl 2 , 2 ATP-Mg, 4 EGTA, and 5 H EPES. The C l Ϫ concentration in this solution (11 mM) was used for the comparison of equilibrium and reversal potentials (see Fig. 2 ). The Z n 2ϩ -free pipette solution contained (in mM): 150 NMDG, 2.48 C aC l 2 , 1.73 MgC l 2 , 2 ATP-Mg, 4 EGTA, and 5 H EPES. The Z n 2ϩ -free and Z n 2ϩ -containing pipette solutions contained different amounts of total C a 2ϩ but identical amounts of calculated free C a 2ϩ (see below). The pH of both of these solutions was adjusted to 7.5 with D-gluconic acid (DGA). In some experiments, the PKC catalytic subunit (#539513; C albiochem, La Jolla, CA), and PKC [19 -31] (#1443 976; Boehringer Mannheim, Indianapolis, I N) were first dissolved into water to a concentration 1000 times higher than the final one and then diluted into the Z n 2ϩ -free pipette solution to the final concentration immediately before experiments. In perforatedpatch mode, the pipette tip was filled with a solution containing (in mM): 150 C sOH, 3.5 C aC l 2 , 4 MgC l 2 , 10 BAP TA, and 5 H EPES; pH was adjusted to 7.5 with DGA. The pipette shank was filled with the above solution mixed at 500:1 with a solution of 3.3% (w/ v) amphotericine B (Sigma, St. L ouis, MO) and 10% (w/ v) pluronic (P-1572; Molecular Probes, Eugene, OR) in DMSO.
The concentrations of free divalent cations in each pipette solution (reported in the text and each figure legend) were calculated using the equations in Chang et al. (1988) and the stability constants in Smith and Martell (1975) corrected for ionic equivalent, pH, and temperature according to the method of Marks and Maxfield (1991) . EGTA was used instead of BAP TA in these experiments, because dissociation constants for the binding of Z n 2ϩ by BAP TA are not available. In the cases of Zn 2ϩ -free solutions, the free C a 2ϩ and Mg 2ϩ values calculated as described above did not differ by Ͼ20% from those calculated using the Bound and Determined software (Brooks and Storey, 1992) implementing the method of Marks and Maxfield (1991) . Unless stated otherwise, the free C a 2ϩ concentration in all pipette solutions was set to levels detected in resting retinal ganglion cells by f ura-2 fluorescence intensity [100 nM (Bindokas et al., 1994) ]. The free Z n 2ϩ concentration in the pipette solution routinely used for ruptured-patch recordings (30 nM) was selected because it falls within the range of concentrations measured in a variety of intact cells (cf. Sensi et al., 1997) and because micromolar Zn 2ϩ has consistently been found to inhibit PKC activity in biochemical studies (Murakami et al., 1987; C sermely et al., 1988; Sekiguchi et al., 1988) . We know of no method that could have been used during the ruptured-patch recordings reported here to demonstrate the precise distribution and concentration of Z n 2ϩ established in the cell cytoplasm by exchange with the pipette solution.
The standard bath solution contained (in mM): 105 Na-DGA, 18 NaC l, 0.001 tetrodotoxin (TTX), 0.1 C aC l 2 , 2.4 CoC l 2 , 30 tetraethylammonium (TEA)-C l, 3 4-aminopyridine (4-AP), 10 D-glucose, and 5 H EPES; pH was adjusted to 7.5 with NaOH and /or HC l. To prepare a test bath solution, we first dissolved a test agent into an appropriate vehicle solvent to a concentration 1000 times higher than the concentration to be applied. This stock solution was kept at Ϫ30°C for up to 1 week and diluted into the bath solution to the final concentration immediately before experiments. The following solvents were used: water for RpcAM P (C albiochem) and pyrithione-Na (Aldrich, Milwaukee, W I); ethanol for N,N,NЈ,NЈ-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN; C albiochem); methanol for 4,4Ј-di-isothiocyanostilbene-2,2Ј-disulfonic acid (DI DS; Aldrich) and 4-acetamido-4Ј-isothiocyanostilbene-2-2Ј-disulfonic acid (SI TS; Aldrich); and DMSO for bisindolylmaleimide I (C albiochem), calphostin C (C albiochem), and 4-bromo-A23187 (4-BrA23187; C albiochem). The control bath solution contained the same vehicle solvent as the corresponding test bath solution.
Three precautions were exercised routinely during this study. First, the ruptured-patch pipette solution, the perforated-patch pipette solution, and bath solutions were adjusted with sucrose to 320 Ϯ 5, 330 Ϯ 5, and 330 Ϯ 5 mOsm / kg, respectively. With these osmolalities, neither swelling nor shrinkage of cells occurred after giga-seal formation. Second, DI DSsensitive current was measured in individual cells by digital subtraction of currents recorded before and during a single application of DI DS, because multiple applications irreversibly altered the kinetics and degree of I C l deactivation in many cells and because retinal ganglion cells possess a K ϩ current (I B ) that resists block by TEA, 4-AP, and C s ϩ (L ukasiewicz and Werblin, 1988; Sucher and Lipton, 1992) . Changes of I C l amplitude produced by pharmacological treatments that augment or block PKC activity were gauged either with a single DI DS application at the end of an experiment or by comparison of the reversal potential and kinetics of the difference between currents recorded before and during the pharmacological treatments. Third, voltage-gated cation currents were suppressed as follows: Na ϩ current was blocked by inclusion of 1 M TTX, Ca 2ϩ currents were blocked by 2.4 mM Co 2ϩ and reduced Ca 2ϩ (0.1 mM), K ϩ currents (except I B ) were blocked by 30 mM TEA and 3 mM 4-AP, and hyperpolarization-activated cation current (I h ) was suppressed by excluding K ϩ from the bath solution (see Bindokas et al., 1994; Tabata and Ishida, 1996; Hidaka and Ishida, 1998) .
RESULTS
In the presence of pharmacological blockers of voltage-gated Na ϩ , K ϩ , and Ca 2ϩ currents (TTX, TEA ϩ , 4-AP, and Co 2ϩ ), depolarization of retinal ganglion cell somata activated an outwardly rectifying current whose amplitude was reduced by agents that block voltage-gated Cl Ϫ current in other tissues. This current appeared to be carried by Cl Ϫ ions-and will be referred to hereafter as I C l -because its reversal potential shifted with the chloride equilibrium potential (E C l ) calculated from the Cl Ϫ ion concentrations in the bath and pipette solutions used. A current with similar voltage sensitivity and pharmacological properties was also recorded when Na ϩ and K ϩ in the bath and recording pipette solutions were replaced by NMDG and TEA ϩ . I C l activated in every cell from which we recorded, in ruptured-as well as perforated-patch recording modes (n ϭ 65 and 51, respectively). When activated by 100 msec depolarizations from holding potentials between Ϫ90 and Ϫ70 mV, to test potentials between Ϫ80 and ϩ40 mV, I C l displayed the following pharmacological properties and voltage sensitivity.
Pharmacology

Several Cl
Ϫ channel blockers were tested, and total whole-cell current (between Ϫ80 and ϩ40 mV) was reduced in amplitude by extracellular application of DIDS (n ϭ 61; e.g., Fig. 1 A) and furosemide (data not shown). This reduction by DIDS and the outward rectification recorded under control conditions ( Fig. 1 B) were not observed if SITS was included in the pipette solution in ruptured-patch mode (consistent with block of the DIDSsensitive current by intracellular SITS; n ϭ 6; Fig. 1C,D) . By contrast, whole-cell current was unaffected by extracellular applications of 100 M picrotoxinin or 500 nM chlorotoxin (n ϭ 3 and 6, respectively; data not shown).
Nearly maximal reduction of the control current amplitude was produced by 1 mM DIDS. The current that resisted block by 1 mM DIDS constituted approximately one-third of the total outward current recorded at a test potential of ϩ40 mV. When normalized to cell capacitance (C m ), the amounts of current that resisted block by DI DS resembled the total whole-cell current recorded (at ϩ40 mV) with pipette solutions that contained 300 M SITS (0.4 Ϯ 0.4 pA /pF; n ϭ 6; see Fig. 1C ). These DI DS-and SITSresistant currents were not examined in detail. However, after repolarization to the holding potential, the amplitude of the "tail" of these currents was K ϩ -sensitive (n ϭ 31; data not shown). We presume that this current is analogous to the TEA-and 4-APresistant cation current termed I B in retinal ganglion cells of other species (L ukasiewicz and Werblin, 1988; Sucher and Lipton, 1992) and that it is carried by other cations (primarily Na ϩ in ruptured-patch mode and C s ϩ in perforated-patch mode) under our recording conditions, as in other neurons (Z hu and Ikeda, 1993; C allahan and Korn, 1994) . This observation indicates that, at the concentrations used, DI DS did not abolish voltagesensitive currents nonselectively in the cells from which we recorded.
Charge carrier and Ca 2؉ insensitivity
Two results indicated that 1 mM DI DS reduced the amplitude of a Cl Ϫ current in retinal ganglion cells under the recording conditions used here. First, as mentioned above, this current reversed in direction at a membrane potential that shifted with extracellular C l Ϫ concentration (Fig. 2) . When the external C l Ϫ concentration was changed from 53 to 11 mM (by isosmotic replacement with D-gluconic acid, with the internal C l Ϫ concentration fixed at 11 mM), the reversal potential of the DI DS-sensitive current shifted from Ϫ36 Ϯ 2 mV (n ϭ 9) to Ϫ3 Ϯ 3 mV (n ϭ 4). These results suggest that this current is carried at least primarily by Cl Ϫ ions, as characteristically found in background Cl Ϫ currents of various cells (Franciolini and Petris, 1990) . (From the bath and pipette solution compositions, the equilibrium potentials for Na ϩ and Ca 2ϩ ions are estimated to have been extremely positive values and to have remained constant while the Cl Ϫ reversal potential changed during these measurements.) Second, the reversal potential of the DIDS-sensitive current was unaffected by a 59 mV shift in the H ϩ equilibrium potential (produced by 0.5 pH unit increases and decreases in extracellular pH; n ϭ 6; Fig.  2 ). Our records thus showed no detectable amounts of the DIDSsensitive proton current described in human macrophages (Holevinsky et al., 1994) .
Two results indicated that the DIDS-sensitive current was not gated by intracellular Ca 2ϩ . First, no increases in current amplitude were detected when cells were exposed to a divalent cation ionophore (4-BrA23187) in the presence of 0.1 mM Ca 2ϩ (n ϭ 5; see Fig. 5 and its description below). Second, the DIDS-sensitive current density (current amplitude normalized to cell membrane capacitance) did not significantly differ when measured in ruptured-patch mode with pipette solutions containing calculated free Ca 2ϩ levels of 10, 30, and 300 nM (n ϭ 4, 5, and 3, respectively; data not shown). Although the density of I C l was indistinguishable when these different pipette solutions were used, the total depolarization-activated outward current density more than doubled at ϩ40 mV (the test potential used routinely to characterize I C l ) when these solutions contained K ϩ rather than Figure 1 . DIDS and SITS reduce an outwardly rectif ying current in the presence of Na ϩ , Ca 2ϩ , and K ϩ current blockers. A, Whole-cell current activated in ruptured-patch mode by the voltage protocol schematically shown above current traces at lef t. The holding potential (E hold ) was Ϫ70 mV; test potentials (E test ) were from Ϫ80 to ϩ40 mV, in 20 mV increments. Currents were recorded before (lef t) and during (middle) application of 1 mM DIDS. Subtraction of these currents yields DI DS-sensitive current (right). The difference current appears to activate rapidly, not inactivate, and then deactivate rapidly (at onset, plateau, and offset, respectively, of each test depolarization). In this and all other current traces, the zero current level is shown by a dotted line. B, Current-voltage ( I-V) curve of the DI DS-sensitive current in A. In this and all other I-V curves, current amplitude is averaged over the final 20 msec of 100 msec steps to each test potential and then plotted against test potential. Current reverses direction near E Cl (Ϫ40 mV). C, Whole-cell current recorded from a cell different from that in A before (lef t) and during (middle) application of 1 mM DI DS. Current was activated and recorded as described in A, except that 100 M SI TS was included in the recording pipette solution. Ionic current recorded under this condition is unaffected by 1 mM DIDS; the difference between currents before and during DI DS (right) is due to slight capacitive current changes only. D, I-V curve measured from the difference of currents in C. The calculated free concentration of Z n 2ϩ in the pipette solution ([Z n 2ϩ ] pip ) was 30 nM.
NMDG as the major monovalent cation and when the calculated free C a 2ϩ level was increased from 10 to 300 nM. These results are consistent with the presence of a C a 2ϩ -activated K ϩ conductance in goldfish retinal ganglion cells, not unlike that suggested by measurements in salamander, turtle, rat, and cat retinal ganglion cells (see Ishida, 1995) . By contrast, the activation of the I C l we report here apparently does not require increases in cytoplasmic C a 2ϩ and thus differs from the C a 2ϩ -activated C l Ϫ current of rod and cone photoreceptors, retinal bipolar cells, and other central neurons (Bader et al., 1982; Maricq and Korenbrot, 1988; Okada et al., 1995) .
On the basis of the above results and to obviate the need for leak-current subtraction, we measured I C l in the remainder of this study by the difference between whole-cell current recorded before and during application of 1 mM DI DS. The amplitude, reversal potential, and kinetics of I C l were measured from these "difference currents." In some cases, we also inferred that I C l was susceptible to regulation by pharmacological agents that affect protein kinase activities, if the difference currents recorded before and during application of these agents resembled the DIDS difference currents.
Gating in ruptured-and perforated-patch modes
The activation range of I Cl included membrane potentials that were more negative and more positive than the E Cl routinely used in our experiments (Ϫ40 or Ϫ32 mV); I Cl was inward at test potentials more negative than E Cl , and it was outward at more positive test potentials (see Figs. 1 B, 7H ) . The chord conductance measured from outward currents exceeded that measured from inward currents when the bath and pipette solutions contained equal Cl Ϫ concentrations and when the standard bath and pipette solutions were used (bath, 53 mM Cl Ϫ ; pipette, 11 mM Cl Ϫ ). When the bath and pipette solutions both contained 11 mM Cl Ϫ , for example, the outward I Cl at ϩ40 mV was 2.9 Ϯ 0.3 (n ϭ 4) times larger in amplitude than the inward I Cl measured at Ϫ40 mV.
Over the range of test potentials we routinely used (i.e., between Ϫ80 and ϩ40 mV), I C l did not exhibit markedly timedependent gating kinetics. First, its rise time was both rapid and not obviously voltage dependent; the rising edge of currents measured after depolarizations to test potentials between Ϫ40 and ϩ40 mV could all be fitted by single-exponential time constants of 3-5 msec. Second, I C l was not detectably inactivated by depolarization because it did not decline in amplitude during sustained depolarizations (Fig. 1) and because the currents activated by depolarizations from Ϫ90 to ϩ20 mV were identical in amplitude to those activated by depolarizations from Ϫ30 to ϩ20 mV (n ϭ 5; data not shown). Third, tail currents were immeasurably small, and thus I C l displayed no time-dependent deactivation (Fig. 1) . It was possible to activate I C l of stable amplitude repeatedly in perforated-patch mode but not in ruptured-patch mode with the standard pipette solution. This was gauged, as explained above, in two steps. The total whole-cell current was measured during the last 20 msec of 100 msec depolarizations, repeated once per 60 sec, from a holding potential of Ϫ70 mV to a test potential of ϩ40 mV; 1 mM DIDS was then applied to determine the fraction of the total current that was comprised by I C l . During ruptured-patch recordings, the amplitude of the total test current increased continuously and by as much as 10-fold or more during the course of 30 min (Fig. 3A) . We infer that this increase in total whole-cell current is attributable primarily, if not entirely, to increases in I C l because 1 mM DIDS blocked approximately all of the total current that (by the end of each recording) exceeded the levels recorded at the beginning of each recording ( Fig. 3A ; the possibility that higher concentrations of DIDS might produce larger reductions in the whole-cell current was not tested). During these long-term recordings, the slowly rising current recorded during the first few milliseconds of each test depolarization and the total whole-cell current tail recorded after repolarization to the holding potential did not markedly change in amplitude. These current components therefore vanished upon subtraction of the current traces recorded in the presence and absence of DIDS (Fig. 1) , leaving traces that show no time-dependent activation or deactivation (of I C l ). The steady growth of I C l illustrated by Figure 3A was never seen in perforated-patch mode. Instead, the amplitude of the total current decreased within the first 5-10 min of giga-seal formation and was stable thereafter for at least 30 min (Fig. 3B) . The initial decline in current amplitude presumably reflects the slow replacement of intracellular K ϩ by Cs ϩ in the pipette solution.
It was technically infeasible to quantify the rate at which I C l increased over time in ruptured-patch mode by alternating applications of control and DIDS-containing bath solution, because applications of DIDS produced changes in the deactivation kinetics of the total current. Nevertheless, the above results imply that at least some of the current measured during 100 msec test depolarizations may be regulated via an intracellular molecule or mechanism that was lost or compromised by exposure to the ruptured-patch pipette solution. These results also indicate that the slowly rising and tail current components can both be activated repeatedly, without substantial change, in ruptured-as well as perforated-patch recordings.
Regulation of I Cl by a zinc-dependent mechanism
We tested the possibility that the increase in amplitude of I C l during recordings in ruptured-patch mode resulted from chelation of cytoplasmic Zn 2ϩ by EGTA in the pipette solution rather than from chelation of Ca 2ϩ . We tested this possibility because Interpolated values of reversal potential (E rev ) of DI DS-sensitive current (measured as described in Fig. 1 B) 
Zn
2ϩ has been detected in the cytoplasm of various central neurons (Frederickson, 1989) and because EGTA binds Zn 2ϩ with a greater affinity than it does other divalent cations (e.g., Ca 2ϩ and Mg 2ϩ ; see Materials and Methods). A first test of this possibility was made by including Z n 2ϩ in the pipette solution used in ruptured-patch mode. When Z n 2ϩ was included in the pipette solution at a free concentration calculated to be 30 nM, the density of I C l (measured at 12-15 min after membrane rupture) ranged from 0.3 to 1.8 pA /pF (mean Ϯ SD; 1.1 Ϯ 0.6; n ϭ 6). Without an exogenous supplement of Z n 2ϩ , I C l density ranged from 0.5 to 7.2 pA /pF (mean Ϯ SD; 2.6 Ϯ 2.3; n ϭ 7; Fig. 3C ). The variance of the current densities measured with the Zn 2ϩ -free pipette solution was significantly larger than that measured with the Zn 2ϩ -containing pipette solution ( p Ͻ 0.01, F test), suggesting that the growth of I C l was often facilitated by the replacement of cytoplasmic constituents by a Z n 2ϩ -free solution and that this growth was hindered by the inclusion of Z n 2ϩ in the pipette solution. Large increases in I C l were not observed with pipette solutions containing a calculated free Z n 2ϩ concentration of 3 nM (n ϭ 2). However, I C l densities were not compared in detail at different pipette Z n 2ϩ concentrations because we had no means to ascertain the Z n 2ϩ levels established within cells during the recordings attempted here. Under both conditions studied (30 nM vs no free Z n 2ϩ ), the difference between currents measured before and after DI DS application displayed outward rectification, rapid activation, no inactivation, and no time-dependent deactivation.
A second test of whether the availability of cytoplasmic Zn 2ϩ abated the growth of I C l was made by superf using cells with the membrane-permeable Z n 2ϩ -selective chelator TPEN (Arslan et al., 1985) in perforated-patch mode. At 10 M, TPEN increased the amplitude of the total whole-cell current at a test potential of ϩ40 mV (Fig. 4 A, E) . The TPEN-augmented difference current (obtained by subtraction of currents recorded before and after application of TPEN) was indistinguishable from I C l in that it rectified outwardly, reversed direction at Ϫ27 Ϯ 3 mV (when E C l was Ϫ32 mV; n ϭ 5; see Fig. 4 for details) , and lacked the inward tail component recorded both in the presence and absence of DIDS (Fig. 1 A) . This effect of TPEN was prevented by coapplication (of TPEN) with Z n 2ϩ (Fig. 4C,D) , as expected because TPEN is membrane impermeant when it has complexed with Zn 2ϩ (Arslan et al., 1985) . A third test of the effect of cytoplasmic Z n 2ϩ on I C l was made by microperfusing a mixture of Zn 2ϩ plus an ionophore that conducts Zn 2ϩ onto cells during recordings in perforated-patch mode. As shown in Figure 5A , the amplitude of outward current activated at a test potential of ϩ40 mV declined in amplitude (Fig. 5 A, B,E) after the coapplication of 1-100 M Zn 2ϩ either with 4-BrA23187 [10 M (Erdahl et al., 1996) ] or with pyrithione [20 -100 M (Zalewski et al., 1993) ]. When coapplied with 4-BrA23187, 1 M Zn 2ϩ (n ϭ 3), 10 M Zn 2ϩ (n ϭ 5), and 100 M Zn 2ϩ (n ϭ 3) produced declines of similar amplitude. Neither Zn 2ϩ nor 4-BrA23187 alone reduced I total at the concentrations used here, and moreover, similar declines in I total were produced by the coapplication of Zn 2ϩ and 4-BrA23187 when the coapplication was preceded by an application of Zn 2ϩ alone (n ϭ 8) or of 4-BrA23187 alone (n ϭ 3). This suggests that the decline in I total resulted from rises in intracellular Zn 2ϩ concentration and not from a 4-BrA23187-mediated influx of Ca 2ϩ or from an effect of Zn 2ϩ on the external membrane surface. The zinc-damped difference current obtained by subtraction of currents recorded before and after these treatments was indistinguishable from I C l in that it rectified outwardly, reversed direction close to E C l (Fig.  5F ), and displayed no time-dependent deactivation. The decline produced by coapplication of Zn 2ϩ and pyrithione was small (0.5 pA/pF; n ϭ 2) and not examined in detail.
Downward regulation of I Cl by an endogenous, zinc-dependent PKC
The results described in the preceding section suggest that the amplitude of whole-cell I C l is downwardly regulated, either directly or indirectly, by cytoplasmic Zn 2ϩ . We tested the possibility that this effect is exerted indirectly for four reasons: (1) because studies of direct Zn 2ϩ effects on Cl Ϫ channels in other cell types used substantially higher Zn 2ϩ concentrations than those used here (see introductory remarks), (2) because biochemical assays have shown that (aside from modulating ion channel activities) Zn 2ϩ facilitates PKC activity (e.g., Murakami et al., 1987; Csermely et al., 1988) , (3) because PKC has been found to modulate Cl Ϫ currents in a variety of cells (e.g., Madison et al., 1986; Li et al., 1989; Kokubun et al., 1991; Tricarico et al., 1991; Kawasaki et al., 1994; Staley, 1994; Coca-Prados et al., 1995; Duan et al., 1997) , and (4) because PKC has been localized by immunocytochemical methods to retinal ganglion cells of the species used here (Osborne et al., 1992) . We therefore tested whether I C l is regulated by endogenous PKC activity and whether this control was zinc dependent.
We first tested the effect of extracellularly applied PKC inhibitors on I C l in perforated-patch mode. Both agents tested (0.1-1 M calphostin C and 1 M bisindolylmaleimide I) (cf. Shapiro et al., 1996) produced an increase in the amplitude of the total outward current (n ϭ 4 for each agent; Fig. 6G ). At a test potential of ϩ40 mV, current amplitude increased noticeably (e.g., by 10 -20%) over the control value within 4 -8 min after application of either agent (Fig. 6 A, C) . Current amplitude continued to increase thereafter during applications of either agent for as long as 10 -15 min. We infer that increases in the amplitude of I C l account for most (if not all) of the increases in outward current observed, because the latter were reduced by DIDS (1 mM) and because the kinetics and voltage sensitivity of the difference current traces obtained by subtraction of currents recorded before and after exposure to PKC inhibitors (Fig.  6 B, D,H ) resemble those of the Cl Ϫ current described above (Fig.  1) . These results suggest that I C l is reduced in resting retinal ganglion cells by an endogenous PKC activity. Figure 4 . The membrane-permeable Z n chelator TPEN augments total whole-cell current (I total ). A, Amplitude of I total activated by depolarization from Ϫ70 to ϩ40 mV, in perforated-patch mode, before and after application of TPEN (10 M; indicated by horizontal bar) is shown. Here and in all subsequent figures, application of the test agent of interest begins at 0 min; current measurements before 0 min (with or without conditioning agents) are plotted against negative time values. Note that the increase in current peaks at 6 -8 min after TPEN application begins. B, Difference between currents activated before and after TPEN at test potentials between Ϫ80 and ϩ40 mV is shown. C, D, TPEN (10 M) fails to augment I total when coapplied with equimolar Z n 2ϩ . E, The current density change produced by TPEN and by a mixture of TPEN and Z n 2ϩ at ϩ40 mV is shown. Current density measured 8 min after drug application began, minus that at 1 min before drug application, is plotted ( filled vertical bars and error bars plot mean Ϯ 1 SEM, respectively; n ϭ 5 for each treatment). The mean change with TPEN is significantly larger than that with TPEN and Z n 2ϩ (*p ϭ 0.0216). F, I-V relation of TPENaugmented current is shown ( filled circles and error bars plot mean Ϯ SEM, respectively; n ϭ 5). Amplitude is normalized to the value at ϩ40 mV and plotted against test potential. E rev , Ϫ27 Ϯ 3 mV; E Cl , Ϫ32 mV. In all panels, currents were recorded in the control bath solution before TPEN application. TPEN was then superf used for 3-4 min after replacing the bath Co 2ϩ with C a 2ϩ (because TPEN binds Co 2ϩ more than Ca 2ϩ and only unbound TPEN can pass through cell membranes). Effects of TPEN were assessed by recording currents after replacing the TPENand Ca 2ϩ -containing solution with control (Co 2ϩ -containing) solution to bind residual TPEN (if any) and to block voltage-gated C a 2ϩ currents. Figure 5 . Effects of Z n 2ϩ "loading" and PKC inhibition on total wholecell current (I total ) in perforated-patch mode. The cytoplasmic Zn 2ϩ level was raised by extracellular application (indicated by horizontal bars) of ZnCl 2 (Zn) together with the Z n 2ϩ -preferring ionophore 4-BrA23187 (BrA). Endogenous PKC was blocked by preincubation with calphostin C (CC). A, C, Amplitude of I total at ϩ40 mV plotted against recording time. Each panel is from a single cell. The dotted line indicates current level before coapplication of Zn and BrA. A, Sequential application of 100 M Zn and 10 M BrA. I total begins to decline after coapplication commences (at t ϭ 0 min); within the next 8 min, current reduction is maximal. C, Sequential application of 10 M Zn and 10 M BrA, preceded by a 30 min preincubation in 1 M CC. I total remains constant during the 10 min coapplication of Zn and BrA. B, D, Difference between I total recorded 1 min before and 10 min after coapplication of Zn and BrA. Current traces in B and D are from cells in A and C, respectively. The voltage protocol is as described in Figure 1 (E hold , Ϫ70 mV; E test , Ϫ80 to ϩ40 mV; 20 mV steps). E, Reduction in I total after 10 min coapplication of Zn and BrA, with and without 30 min preincubation in 1 M CC. Filled vertical bars and error bars plot the mean and SEM, respectively, of the reduction in current amplitude at ϩ40 mV, divided by C m to normalize for cell size. Current reduction by Zn is significantly greater without CC than with CC (*p ϭ 0.0058), indicating that reduction of I Cl by Zn can be blocked by inhibition of endogenous PKC. CC/Zn & BrA, Coapplication of 10 M Zn and 10 M BrA after preincubation (n ϭ 5); Zn & BrA, coapplication of 1-10 M Zn and 10 M BrA without preincubation (n ϭ 7). F, I-V curve of current reduced by coapplication of Zn (1-10 M) and BrA (10 M). Filled circles plot the mean of difference current amplitudes measured as described in B (n ϭ 6). Means are normalized to the value at ϩ40 mV. Error bars indicate 1 SEM. E rev , Ϫ34.5 Ϯ 5 mV.
As might therefore be expected, DI DS-sensitive current was undetectably small when PKC catalytic subunit (ϳ4 pM) was included in pipette solutions during ruptured-patch recordings (n ϭ 5; Fig. 7A ). Moreover, DI DS-sensitive current (I C l ) could be activated when a PKC inhibitor ) (cf. Lin et al., 1994) and PKC catalytic subunit were included together in the pipette solution during ruptured-patch recordings (n ϭ 5 for each treatment; Fig. 7) . Therefore, the observed reduction of I C l amplitude cannot be ascribed to nonspecific effects of the PKC catalytic subunit (i.e., effects beside phosphorylation).
Lastly, we tested whether the downward regulation of I C l by endogenous PKC and that by cytoplasmic Zn 2ϩ were linked. This was done by measuring I total in the presence of calphostin C, Zn 2ϩ , and 4-BrA23187. Figure 5 , C and E, shows that 10 M Zn 2ϩ and 10 M 4-BrA23187 did not reduce the amplitude of I total in cells incubated for 30 min in 1 M calphostin C. The subtraction of currents recorded in the presence of all three agents from those recorded in the presence of Zn 2ϩ and calphostin C alone showed no measurable difference current at any of the test potentials used (n ϭ 5; Fig. 5D ; only slight changes in capacitive current artifacts are seen at the onset and offset of the test potentials). The current reduction by Zn 2ϩ was significantly less after Ն30 min preincubations with calphostin C than without it ( Fig. 5E ; p ϭ 0.0058), indicating that inhibition of endogenous PKC impeded the reduction of I C l by Zn 2ϩ . Consistent with this and with the lag observed between calphostin C application and I C l augmentation (e.g., Fig. 6 ), I C l amplitude grew monotonically if 10 M Zn 2ϩ and 10 M 4-BrA23187 were coapplied after a 10 min (rather than 30 min) exposure to 1 M calphostin C (n ϭ 5; data not shown). All of these results would be expected if the reduction of I C l by cytoplasmic Zn 2ϩ (like that shown in Fig. 5A ) was mediated by PKC.
Under the same recording conditions in which PKC inhibitors increased I C l , the Rp-isomer of cAMP (0.1-1 mM) produced no detectable change in I C l when applied onto cells by microperfusion for as long as 25 min (Fig. 6G,H ) . Because Rp-cAMP is a membrane-permeable inhibitor of protein kinase A (PKA) and because the concentrations used are 10 -100 times greater than its K i , we did not further test whether endogenous PKA activity regulates I C l .
DISCUSSION
We have described here an outwardly rectifying Cl Ϫ current (I C l ) whose amplitude appears to be downwardly regulated in a zinc-dependent manner by an endogenous PKC. Below, we discuss the role of zinc in suppressing this current, compare this current with anionic conductances in other cells, and delimit speculation about the function of this current.
Indirect effects of Zn
2؉
Previous studies showed that the open time of outward singlechannel Cl Ϫ currents is reduced by application of 1-10 mM Zn 2ϩ to the cytoplasmic side of isolated membrane patches and interpreted these effects as resulting from a voltage-dependent block (Woll et al., 1987; Kokubun et al., 1991; Groschner and Kukovetz, 1992) . Our results might seem similar in that exposure of cells to Zn 2ϩ and either 4-BrA23187 or pyrithione reduced the amplitude of outward whole-cell Cl Ϫ current (Fig. 5) . However, our results differ from these previous reports in at least three respects. First, both inward and outward Cl Ϫ current amplitudes were augmented by pharmacological treatments that chelate cytoplasmic Zn 2ϩ (exposure to TPEN; buffering divalent cation levels in nominally Zn 2ϩ -free ruptured-patch pipette solutions with EGTA); conversely, both currents were reduced by treatments designed to augment intracellular Zn 2ϩ levels (Figs. 3A, 4B , 5B). These results are not readily explained by assuming a voltagedependent block by Zn 2ϩ like that considered in the outward Cl Ϫ current measurements cited above. Second, inclusion of 30 nM free Zn 2ϩ in our pipette solutions was effective in minimizing Cl Ϫ current increases in the ruptured-patch recording mode. This implies that I C l may be controlled by Zn 2ϩ concentrations several orders of magnitude lower than those applied in the studies cited above (without excluding the possibility that higher Figure 1 . G, Mean change in density of I total at ϩ40 mV after 15-20 min application of various test agents. Bis I, 1 M Bis I; CC, 0.1-1 M CC; cntrl, control bath solutions supplemented with vehicle (DMSO) only; Rp, 0.1-1 mM Rp-cAM P (n ϭ 4 for each treatment). The mean change with CC and Bis I is significantly larger than the control level (*p Ͼ 0.0209 for both). H, I-V relation of current augmented by CC ( filled circles) and Bis I (open circles). Amplitude was normalized to the maximum value recorded from each cell at ϩ40 mV and plotted against test potential. Symbols and error bars plot the mean Ϯ SEM, respectively (n ϭ 4 for each treatment). Voltage sensitivity of these currents resembles those of I Cl in Figure 1 . E rev of CC-and Bis I-augmented currents, Ϫ27 Ϯ 8 and Ϫ28 Ϯ 3 mV, respectively; E Cl , Ϫ32 mV.
Zn
2ϩ concentrations might hinder C l Ϫ channel gating in retinal ganglion cells) (cf. Staley, 1994) . Third, we found that the effect of exogenously supplied cytoplasmic Z n 2ϩ was blocked by the PKC inhibitor calphostin C. This suggests that I C l was not inhibited by Zn 2ϩ alone. If increased cytoplasmic Z n 2ϩ levels reduced I C l independently of PKC in our recordings, then these decreases were so small that they were outweighed by the increases in I C l produced by PKC inhibition (Fig. 5E) .
The similarly slow and marked growth in C l Ϫ current amplitude we observed after exposure to calphostin C and bisindolylmaleimide I, superf usion with TPEN, and internal perf usion with EGTA (without added Z n 2ϩ ) would all be expected if I C l was downregulated by a PKC whose activity depends on Zn 2ϩ . Alone, any one of these results would have corroborated the results of previous studies, as C l Ϫ current blockade by Zn 2ϩ at the cytoplasmic side of membranes and the downward regulation of Cl Ϫ current by PKC have been described separately in other preparations (cited both above and below). Furthermore, PKC has been localized immunocytochemically to retinal ganglion cells in all species examined to date (e.g., Cuenca et al., 1990; Usuda et al., 1991; Osborne et al., 1992; Kolb et al., 1993; Fukuda et al., 1994) . To our knowledge, however, the zinc dependence of the downward regulation of a C l Ϫ current by PKC that we report here is novel. For that matter, our study provides the first electrophysiological evidence consistent with biochemical measurements of zinc-dependent PKC activity in other systems (Murakami et al., 1987; C sermely et al., 1988; Hubbard et al., 1991) . This possibility was not predictable from immunocytochemical studies, as several PKC isozymes have been localized to retinal ganglion cells (e.g., Usuda et al., 1991; Osborne et al., 1992; Kolb et al., 1993) , Z n 2ϩ has not been detected anatomically in retinal ganglion cells (Ugarte and Osborne, 1998) , and Z n 2ϩ that is bound to PKC would not be detectable by any anatomical methods that we are aware of (Frederickson, 1989; Sensi et al., 1997) . However, one of the PKC isozymes (PKC -␤) localized to retinal ganglion cells of the species used in this study (Osborne et al., 1992 ) is a type whose activity has been shown by biochemical methods to be zinc dependent (Murakami et al., 1987; Csermely et al., 1988; Hubbard et al., 1991) . Our results provide independent evidence of such activity, and in the absence of other candidates, we provisionally attribute the PKC -and zincdependent regulation of C l Ϫ current to this isozyme. This possibility could be of general interest because PKC-␤ has also been localized in frog, turtle, rabbit, monkey, and human retinal ganglion cells (Cuenca et al., 1990; Usuda et al., 1991; Osborne et al., 1992; Kolb et al., 1993; Fukuda et al., 1994) .
Cl
؊ current identification
Four types of Cl Ϫ current have been found previously to be reduced in amplitude by PKC activity. However, none of these currents are known to have all of the properties we report here. The Cl Ϫ current blocked by PKC activation in hippocampal pyramidal cells is activated by hyperpolarization and rectifies inwardly (Madison et al., 1986; Staley, 1994) ; large single-channel anion currents recorded after PKC inhibition or membrane patch excision (Kokubun et al., 1991; Groschner and Kukovetz, 1992) display bell-shaped activation curves; Cl Ϫ channels are inactivated by PKC in normal and cystic fibrosis airway epithelia, but only at cytoplasmic Ca 2ϩ concentrations Ͼ150 nM (Li et al., 1989) ; and background Cl Ϫ currents that are reduced by PKC in other preparations [skeletal muscle (Tricarico et al., 1991) ; renal and cardiac ClC-3 channels (Kawasaki et al., 1994; Duan et al., 1997) ; and ciliary epithelium (Coca-Prados et al., 1995) ] have yet to be examined for cytoplasmic Zn 2ϩ sensitivity. Cytoplasmic Ca 2ϩ inhibits ClC-3 channel currents (Kawasaki et al., 1995) at levels that did not noticeably alter the I C l reported here. However, the significance of this difference remains to be investigated, because the inhibition by Ca 2ϩ was observed under conditions unlike ours (in the presence of a protein kinase inhibitor and alkaline phosphatase, and in the absence of ATP and Zn 2ϩ ) and because we have been unable to make stable whole-cell recordings from retinal ganglion cells in hypotonic or isotonic bath solutions (see Materials and Methods).
The background I C l we have found in retinal ganglion cells also appears to be distinct from all five types of Cl Ϫ current described in other retinal cells. I C l was not detectably affected by cytoplasmic Ca 2ϩ levels buffered (nominally) to between 3 and 300 nM and thus differs from the Ca 2ϩ -activated Cl Ϫ current of photoreceptor and bipolar cells (see Results). In addition, I C l was not blocked by picrotoxinin and thus differs from Cl Ϫ channels complexed with GABA A , GABA C , and glycine receptors (see Wang et al., 1995) . Lastly, I C l was not affected by Rp-cAMP and thus differs from the Cl Ϫ conductance in pigmented epithelial cells (Peterson et al., 1997) . Coincidentally, protein kinase activities Figure 7 . Downregulation of I Cl by PKC-mediated phosphorylation. A, Currents activated by depolarization from Ϫ70 to ϩ40 mV before (lef t column) and during (middle column) application of 1 mM DIDS and with digital subtractions thereof (right column). Each row of currents is from a separate cell, with the ruptured-patch pipette solution containing no peptide (top row), 4 pM PKC catalytic subunit (middle row), or a mixture of 4 pM PKC catalytic subunit and PKC inhibitor [1 M PKC(19 -31)] (bottom row). DI DS was applied to each cell 9 -15 min after formation of ruptured-patch -recording mode. The flat difference current in the middle row shows that there is no current blocked by DIDS in the presence of PKC. The DI DS-sensitive difference current in the bottom row shows I Cl spared by PKC inhibition. B, Density of DIDS-sensitive currents measured as described in A. Filled vertical bars and error bars plot the mean Ϯ SEM; n ϭ 5 for each treatment. In each recording, the pipette solution contained 2 mM ATP and no added Z n 2ϩ . Mean density is significantly reduced by PKC from the control (no peptide) level (*p ϭ 0.0122). Mean density with PKC(19 -31) is significantly larger than those with PKC only (#p ϭ 0.0122).
